Diffuse Malignant Mesothelioma — Trials

Diffuse Malignant Mesothelioma — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02399371	Pembrolizumab in Treating Patients With Malignant Mesothelioma	completed	Phase 2	65	University of ChicagoOTHER	1	May 8, 2026	clinicaltrials
NCT00365053	PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery	completed	Phase 2	13	National Cancer Institute (NCI)NIH	1	Jun 7, 2018	clinicaltrials